Blaine Davis is Chief Financial Officer of Protara Therapeutics, Inc.. Currently has a direct ownership of 20,662 shares of TARA, which is worth approximately $47,315. The most recent transaction as insider was on Jul 15, 2022, when has been sold 5,081 shares (Common Stock) at a price of $3.13 per share, resulting in proceeds of $15,904. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.7K
0% 3M change
0% 12M change
Total Value Held $47,315

Blaine Davis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 15 2022
SELL
Payment of exercise price or tax liability
$15,904 $3.13 p/Share
5,081 Reduced 19.74%
20,662 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
14,100 Added 47.51%
15,581 Common Stock

Also insider at

SELB
SELECTA BIOSCIENCES INC Healthcare
BD

Blaine Davis

Chief Financial Officer
New York, NY

Track Institutional and Insider Activities on TARA

Follow Protara Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TARA shares.

Notify only if

Insider Trading

Get notified when an Protara Therapeutics, Inc. insider buys or sells TARA shares.

Notify only if

News

Receive news related to Protara Therapeutics, Inc.

Track Activities on TARA